evolcSign inStart free
Menu

Cyden

Manufacturer of energy-based at-home skin and hair devices for consumer and professional beauty markets

Swansea, United KingdomFounded 2002cyden.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-29

About Cyden

CyDen designs and manufactures energy-based (IPL-type) beauty devices, moving professional aesthetic technologies into clinically validated at-home products. Services cover research and simulation, clinical testing, embedded software, regulatory approval and high-volume manufacturing, offered as an OEM/ODM partner.

Customers include consumer and professional beauty markets; the company also sells its own SmoothSkin consumer brand and works with a long-standing FMCG partner on IPL hair removal devices. Revenue comes from device manufacturing and development services.

Founded in 2002 and headquartered in Swansea, Wales, the company has offices in Tokyo and London and manufacturing in the UK and China. It reports over 400 colleagues and is hiring across R&D, manufacturing, clinical, regulatory and commercial roles.

Product: Energy-based (IPL) skin and hair devices for at-home and professional use, plus OEM/ODM development and manufacturing services.

Jobs at Cyden

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Dna Worldwide Group Holdings

    DNA testing and related forensic services for individuals, families, immigration applicants and legal cases
    Frome, United KingdomBiotech & pharmaFounded 2023
    Young companyNew on Evolc

  • Dnae Group Holdings

    Point-of-need semiconductor DNA sequencing diagnostics for infection testing in hospital settings, developed in London
    London, United KingdomBiotech & pharmaFounded 2003
    New on Evolc

  • Draig Therapeutics

    Develops neuropsychiatric drug therapies for patients with depression and other brain disorders
    Cardiff, United KingdomBiotech & pharmaFounded 2021
    New on Evolc

  • Duke Street Bio

    Develops cancer therapies targeting DNA damage repair deficiencies for patients with cancer
    London, United KingdomBiotech & pharmaFounded 2020
    New on Evolc

  • Elasmogen

    Biopharma developing ELN28, a dual-acting TNFα and JAK inhibitor conjugate for hidradenitis suppurativa patients
    Foresterhill, United KingdomBiotech & pharmaFounded 2014
    New on Evolc

  • Eleventx

    Extended-release RNA medicines for chronic disease, starting in cardiometabolic, developed with pharma partners
    Cambridge, United KingdomBiotech & pharma2 open jobs

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Google Analytics 4
  • Google reCAPTCHA
  • Meta Pixel
  • WooCommerce
  • WordPress
  • bunny.net
  • jQuery